Patents by Inventor Elina Zorde Khvalevsky

Elina Zorde Khvalevsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNA interference compositions targeting heat shock protein 90 and methods of use thereof
    Patent number: 10006030
    Abstract: This disclosure relates to RNA interference (RNAi) compositions that target expression of heat shock protein 90 (HSP90) in a subject. Polymeric delivery devices for providing the RNAi compositions are also described, as are methods of treating cancer using the described RNAi compositions.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: June 26, 2018
    Assignee: SILENSEED LTD.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky
  • RNA INTERFERENCE COMPOSITIONS TARGETING HEAT SHOCK PROTEIN 90 AND METHODS OF USE THEREOF
    Publication number: 20170283803
    Abstract: This disclosure relates to RNA interference (RNAi) compositions that target expression of heat shock protein 90 (HSP90) in a subject. Polymeric delivery devices for providing the RNAi compositions are also described, as are methods of treating cancer using the described RNAi compositions.
    Type: Application
    Filed: July 14, 2015
    Publication date: October 5, 2017
    Applicant: SILENSEED LTD.
    Inventors: Amotz SHEMI, Elina ZORDE KHVALEVSKY
  • Methods and compositions for treating prostate cancer
    Patent number: 9764035
    Abstract: Treatment of prostate cancer by regional and prolonged release of one or more nucleotide-based RNAi agents is provided.
    Type: Grant
    Filed: March 29, 2015
    Date of Patent: September 19, 2017
    Assignee: SILENSEED LTD.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky, Rachel Malka Gabai
  • Methods and compositions for treating cancer
    Patent number: 9687500
    Abstract: Treatment of cancer by regional and prolonged release of one or more nucleotide-based agents is provided.
    Type: Grant
    Filed: May 14, 2015
    Date of Patent: June 27, 2017
    Assignee: SILENSEED LTD.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky, Rachel Malka Gabai
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20150238517
    Abstract: Treatment of cancer by regional and prolonged release of one or more nucleotide-based agents is provided.
    Type: Application
    Filed: May 14, 2015
    Publication date: August 27, 2015
    Applicant: SILENSEED LTD.
    Inventors: Amotz SHEMI, Elina ZORDE KHVALEVSKY, Rachel MALKA GABAI
  • Methods and Compositions for Treating Prostate Cancer
    Publication number: 20150196648
    Abstract: Treatment of prostate cancer by regional and prolonged release of one or more nucleotide-based RNAi agents is provided.
    Type: Application
    Filed: March 29, 2015
    Publication date: July 16, 2015
    Applicant: SILENSEED LTD.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky, Rachel Malka Gabai
  • Methods and compositions for RNAi-based cancer treatment
    Patent number: 9080173
    Abstract: The present invention generally concerns methods and compositions for treating mutated K-ras expressing cancers.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: July 14, 2015
    Assignee: SILENSEED LTD.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky
  • Methods and compositions for treating prostate cancer
    Patent number: 9006199
    Abstract: Treatment of prostate cancer by regional and prolonged release of one or more nucleotide-based RNAi agents is provided.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: April 14, 2015
    Assignee: Silenseed Ltd.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky, Rachel Malka Gabai
  • METHODS AND COMPOSITIONS FOR RNAI-BASED CANCER TREATMENT
    Publication number: 20150050341
    Abstract: The present invention generally concerns methods and compositions for treating mutated K-ras expressing cancers.
    Type: Application
    Filed: October 29, 2014
    Publication date: February 19, 2015
    Applicant: SILENSEED LTD.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky
  • Methods and compositions for RNAi-based cancer treatment
    Patent number: 8889642
    Abstract: The present invention generally concerns methods and compositions for treating mutated K-ras expressing cancers.
    Type: Grant
    Filed: April 19, 2012
    Date of Patent: November 18, 2014
    Assignee: Silenseed Ltd.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky
  • METHODS AND COMPOSITIONS FOR RNAi-BASED CANCER TREATMENT
    Publication number: 20140314854
    Abstract: The present invention generally concerns methods and nucleotide-based compositions for treating metastatic cancer that is associated with a primary tumor or a few tumors at the primary organ.
    Type: Application
    Filed: October 18, 2013
    Publication date: October 23, 2014
    Applicant: Silenseed Ltd.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky
  • METHODS AND COMPOSITIONS FOR RNAI-BASED CANCER TREATMENT
    Publication number: 20130280329
    Abstract: The present invention generally concerns methods and compositions for treating mutated K-ras expressing cancers.
    Type: Application
    Filed: April 19, 2012
    Publication date: October 24, 2013
    Applicant: Silenseed LTD.
    Inventors: Amotz Shemi, Elina Zorde Khvalevsky